ARA-290 5mg

ARA-290 5mg – Advanced Research Peptide for Neurological, Cellular & Inflammation Studies

ARA-290 5mg, also known as Cibinetide, is a synthetic peptide derived from a specific region of erythropoietin (EPO). Unlike traditional EPO, this peptide has been engineered to eliminate its effects on red blood cell production while retaining powerful tissue-protective and anti-inflammatory properties. This makes it a highly valuable compound in neurological, inflammatory, and regenerative research models.

Because of its unique profile, ARA-290 has gained considerable interest in scientific communities exploring nerve repair pathways, chronic inflammation, autoimmune dysfunction, and metabolic stress conditions. The 5mg concentration offers reliable consistency for repeatable experimentation in laboratory settings.

What Makes ARA-290 Unique?

ARA-290 binds to a specific receptor complex known as the Innate Repair Receptor (IRR). This receptor is activated during tissue damage, inflammation, or stress. By targeting this pathway, ARA-290 supports the body’s natural cellular protection and repair mechanisms without increasing hematocrit or impacting red blood cells like traditional erythropoietin.

This unique mechanism makes it ideal for research related to:

• Nerve damage and regeneration models

• Peripheral and diabetic neuropathy studies

• Chronic inflammation research

• Autoimmune response pathways

• Tissue protection under stress conditions

• Cellular survival and regeneration signaling

In laboratory evaluations, ARA-290 has demonstrated encouraging results in reducing pro-inflammatory markers, modulating immune cell activity, and promoting healthier nerve function signaling.